| abstract |
The polypeptides in the present invention possess the effects of promotingnand inhibiting the secretion of prolactin, and are thus useful as drugs for thenprevention and treatment of various diseases, in terms of prolactin secretionnstimulants, which are associated with the secretion of prolactin, such asnhypoovarianism, spermatic underdevelopment, menopausal symptoms,nhypothyroidism, etc. The polypeptides are useful as drugs for the prevention andntreatment of various diseases, in terms of prolactin secretion inhibitors, which arenassociated with the secretion of prolactin, such as pituitary tumor, diencephalonntumor, menstrual disorder, autoimmune diseases, prolactinoma, sterility, impotence,namenorrhea, lactorrhea, acromegaly, Chiari-Frommel syndrome, Argonz-del Castilonsyndrome, Forbes-Albright syndrome, lymphoma, Sheehan's syndrome,nspermatogenesis disorder, etc. |